Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Strathspey Crown Holdings
Newport Beach, California, United States
- Ownership
- Private
- Employees
- ~27
- Development stage
- Other
01
Overview
Strathspey Crown is a growth equity firm that invests in and partners with healthcare, technology, and fintech companies. The firm does not directly develop drugs but invests in portfolio companies such as AEON Biopharma, which is developing ABP-450 (prabotulinumtoxinA), a botulinum toxin complex in Phase 2 trials for cervical dystonia and migraine prevention.
- Therapeutic areas
- OphthalmologyNeurology
- Modalities
- ProteinDevice
- Industry
- Investors
02
Partnerships
Daewoong PharmaceuticalTEOXANE LaboratoriesBausch and Lomb
Beyond the preview
Go deeper on Strathspey Crown Holdings.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Strathspey Crown Holdings.